LianBio Ownership 2024 | Who Owns LianBio Now?
Institutional Ownership
74.32%
Insider Ownership
5.91%
Retail Ownership
19.78%
Institutional Holders
35.00
LianBio Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | 53.33% | 3.33% | 57,558,451 | - | - | 112,814,563,000 | Mar 31, 2023 |
| CORMORANT ASSET MANAGEMENT, LP | 3.94% | 0.55% | 4,250,000 | 4,250,000 | 100.00% | 8,330,000 | Mar 31, 2023 |
| VIKING GLOBAL INVESTORS LP | 3.30% | 0.03% | 3,564,173 | - | - | 6,950,137,000 | Mar 31, 2023 |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 3.06% | 0.65% | 3,303,573 | - | - | 6,475,003,000 | Mar 31, 2023 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2.35% | 0.00% | 2,537,609 | -143,888 | -5.37% | 4,949,000 | Mar 31, 2023 |
| VIDA VENTURES ADVISORS, LLC | 2.11% | 6.12% | 2,282,084 | - | - | 4,472,885,000 | Mar 31, 2023 |
| WELLINGTON MANAGEMENT GROUP LLP | 0.96% | 0.00% | 1,032,084 | - | - | 2,012,564,000 | Mar 31, 2023 |
| BLACKROCK INC. | 0.95% | 0.00% | 1,023,107 | - | - | 2,005,289,000 | Mar 31, 2023 |
| SCHF (GPE), LLC | 0.87% | 3.24% | 937,500 | - | - | 1,838,000 | Mar 31, 2023 |
| CITIGROUP INC | 0.67% | 0.00% | 723,636 | 16,300 | 2.30% | 1,411,090,000 | Mar 31, 2023 |
| AFFINITY ASSET ADVISORS, LLC | 0.60% | 0.42% | 650,000 | - | - | 1,267,500,000 | Mar 31, 2023 |
| RENAISSANCE TECHNOLOGIES LLC | 0.27% | 0.00% | 296,200 | 5,578 | 1.92% | 581,000 | Mar 31, 2023 |
| LOGOS GLOBAL MANAGEMENT LP | 0.26% | 0.08% | 280,000 | - | - | 548,800,000 | Mar 31, 2023 |
| MILLENNIUM MANAGEMENT LLC | 0.23% | 0.00% | 251,495 | -69,023 | -21.53% | 490,000 | Mar 31, 2023 |
| TANG CAPITAL MANAGEMENT LLC | 0.19% | 0.06% | 209,600 | 150,000 | 251.68% | 410,816,000 | Mar 31, 2023 |
| CASDIN CAPITAL, LLC | 0.19% | 0.03% | 206,415 | - | - | 402,509,000 | Mar 31, 2023 |
| TD ASSET MANAGEMENT INC | 0.17% | 0.00% | 178,519 | - | - | 348,112,000 | Mar 31, 2023 |
| CORNERCAP INVESTMENT COUNSEL INC | 0.15% | 0.06% | 165,400 | -318 | -0.19% | 324,184,000 | Mar 31, 2023 |
| 22NW, LP | 0.13% | 0.17% | 141,223 | - | - | 276,797,000 | Mar 31, 2023 |
| MYDA ADVISORS LLC | 0.11% | 0.09% | 120,000 | -15,000 | -11.11% | 235,200,000 | Mar 31, 2023 |
LianBio's largest institutional shareholder is PERCEPTIVE ADVISORS LLC, holding 53.33% of the company's total share outstanding, currently valued at $112.81B. The top 10 institutional shareholders own together 71.54% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VIDA VENTURES ADVISORS, LLC | 2.11% | 6.12% | 2,282,084 | - | - | 4,472,885,000 | Mar 31, 2023 |
| PERCEPTIVE ADVISORS LLC | 53.33% | 3.33% | 57,558,451 | - | - | 112,814,563,000 | Mar 31, 2023 |
| SCHF (GPE), LLC | 0.87% | 3.24% | 937,500 | - | - | 1,838,000 | Mar 31, 2023 |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 3.06% | 0.65% | 3,303,573 | - | - | 6,475,003,000 | Mar 31, 2023 |
| CORMORANT ASSET MANAGEMENT, LP | 3.94% | 0.55% | 4,250,000 | 4,250,000 | 100.00% | 8,330,000 | Mar 31, 2023 |
| AFFINITY ASSET ADVISORS, LLC | 0.60% | 0.42% | 650,000 | - | - | 1,267,500,000 | Mar 31, 2023 |
| 22NW, LP | 0.13% | 0.17% | 141,223 | - | - | 276,797,000 | Mar 31, 2023 |
| MYDA ADVISORS LLC | 0.11% | 0.09% | 120,000 | -15,000 | -11.11% | 235,200,000 | Mar 31, 2023 |
| LOGOS GLOBAL MANAGEMENT LP | 0.26% | 0.08% | 280,000 | - | - | 548,800,000 | Mar 31, 2023 |
| TANG CAPITAL MANAGEMENT LLC | 0.19% | 0.06% | 209,600 | 150,000 | 251.68% | 410,816,000 | Mar 31, 2023 |
| CORNERCAP INVESTMENT COUNSEL INC | 0.15% | 0.06% | 165,400 | -318 | -0.19% | 324,184,000 | Mar 31, 2023 |
| OLD WELL PARTNERS, LLC | 0.03% | 0.05% | 32,200 | - | - | 63,112,000 | Mar 31, 2023 |
| CASDIN CAPITAL, LLC | 0.19% | 0.03% | 206,415 | - | - | 402,509,000 | Mar 31, 2023 |
| VIKING GLOBAL INVESTORS LP | 3.30% | 0.03% | 3,564,173 | - | - | 6,950,137,000 | Mar 31, 2023 |
| VIDENT INVESTMENT ADVISORY, LLC | 0.03% | 0.00% | 27,778 | -838 | -2.93% | 54,445,000 | Mar 31, 2023 |
| CITIGROUP INC | 0.67% | 0.00% | 723,636 | 16,300 | 2.30% | 1,411,090,000 | Mar 31, 2023 |
| RENAISSANCE TECHNOLOGIES LLC | 0.27% | 0.00% | 296,200 | 5,578 | 1.92% | 581,000 | Mar 31, 2023 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2.35% | 0.00% | 2,537,609 | -143,888 | -5.37% | 4,949,000 | Mar 31, 2023 |
| TD ASSET MANAGEMENT INC | 0.17% | 0.00% | 178,519 | - | - | 348,112,000 | Mar 31, 2023 |
| WELLINGTON MANAGEMENT GROUP LLP | 0.96% | 0.00% | 1,032,084 | - | - | 2,012,564,000 | Mar 31, 2023 |
The largest LianBio shareholder by % of total assets is VIDA VENTURES ADVISORS, LLC. The company owns 2.28M shares of LianBio (LIAN), representing 6.12% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CORMORANT ASSET MANAGEMENT, LP | 3.94% | 0.55% | 4,250,000 | 4,250,000 | 100.00% | 8,330,000 | Mar 31, 2023 |
| TANG CAPITAL MANAGEMENT LLC | 0.19% | 0.06% | 209,600 | 150,000 | 251.68% | 410,816,000 | Mar 31, 2023 |
| CITIGROUP INC | 0.67% | 0.00% | 723,636 | 16,300 | 2.30% | 1,411,090,000 | Mar 31, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.01% | - | 15,494 | 15,494 | 100.00% | 30,213,000 | Mar 31, 2023 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.01% | - | 12,536 | 12,536 | 100.00% | 24,445,000 | Mar 31, 2023 |
| RENAISSANCE TECHNOLOGIES LLC | 0.27% | 0.00% | 296,200 | 5,578 | 1.92% | 581,000 | Mar 31, 2023 |
| COMMONWEALTH EQUITY SERVICES, LLC | 0.01% | 0.00% | 13,830 | 3,000 | 27.70% | 27,000 | Mar 31, 2023 |
| STIFEL FINANCIAL CORP | 0.02% | 0.00% | 23,534 | 2,284 | 10.75% | 46,127,000 | Mar 31, 2023 |
| BANK OF AMERICA CORP /DE/ | 0.01% | - | 12,783 | 251 | 2.00% | 25,055,000 | Mar 31, 2023 |
| MORGAN STANLEY | 0.00% | - | 1,001 | - | - | 1,962,000 | Mar 31, 2023 |
| BLACKROCK INC. | 0.95% | 0.00% | 1,023,107 | - | - | 2,005,289,000 | Mar 31, 2023 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 0.11% | 0.00% | 117,484 | - | - | 229,094,000 | Mar 31, 2023 |
| CARY STREET PARTNERS INVESTMENT ADVISORY LLC | 0.00% | 0.00% | 1,000 | - | - | 1,960,000 | Mar 31, 2023 |
| WELLINGTON MANAGEMENT GROUP LLP | 0.96% | 0.00% | 1,032,084 | - | - | 2,012,564,000 | Mar 31, 2023 |
| TD ASSET MANAGEMENT INC | 0.17% | 0.00% | 178,519 | - | - | 348,112,000 | Mar 31, 2023 |
| VIKING GLOBAL INVESTORS LP | 3.30% | 0.03% | 3,564,173 | - | - | 6,950,137,000 | Mar 31, 2023 |
| CASDIN CAPITAL, LLC | 0.19% | 0.03% | 206,415 | - | - | 402,509,000 | Mar 31, 2023 |
| OLD WELL PARTNERS, LLC | 0.03% | 0.05% | 32,200 | - | - | 63,112,000 | Mar 31, 2023 |
| LOGOS GLOBAL MANAGEMENT LP | 0.26% | 0.08% | 280,000 | - | - | 548,800,000 | Mar 31, 2023 |
| 22NW, LP | 0.13% | 0.17% | 141,223 | - | - | 276,797,000 | Mar 31, 2023 |
As of Mar 31 2023, LianBio's largest institutional buyer is CORMORANT ASSET MANAGEMENT, LP. The company purchased 4.25M stocks of LIAN, valued at $8.33M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VR ADVISER, LLC | - | - | - | -4,793,047 | -100.00% | - | Mar 31, 2023 |
| INNOVIS ASSET MANAGEMENT LLC | - | - | - | -176,192 | -100.00% | - | Mar 31, 2023 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2.35% | 0.00% | 2,537,609 | -143,888 | -5.37% | 4,949,000 | Mar 31, 2023 |
| THRIVENT FINANCIAL FOR LUTHERANS | - | - | - | -81,168 | -100.00% | - | Mar 31, 2023 |
| MILLENNIUM MANAGEMENT LLC | 0.23% | 0.00% | 251,495 | -69,023 | -21.53% | 490,000 | Mar 31, 2023 |
| BARCLAYS PLC | 0.06% | 0.00% | 62,269 | -66,459 | -51.63% | 122,000 | Mar 31, 2023 |
| VICTORY CAPITAL MANAGEMENT INC | - | - | - | -64,506 | -100.00% | - | Mar 31, 2023 |
| CITADEL ADVISORS LLC | 0.10% | - | 111,762 | -30,431 | -21.40% | 217,935,000 | Mar 31, 2023 |
| JANE STREET GROUP, LLC | 0.02% | - | 26,381 | -21,202 | -44.56% | 51,707,000 | Mar 31, 2023 |
| GSA CAPITAL PARTNERS LLP | - | - | - | -19,482 | -100.00% | - | Mar 31, 2023 |
| VIRTU FINANCIAL LLC | - | - | - | -17,456 | -100.00% | - | Mar 31, 2023 |
| MYDA ADVISORS LLC | 0.11% | 0.09% | 120,000 | -15,000 | -11.11% | 235,200,000 | Mar 31, 2023 |
| HIGHTOWER ADVISORS, LLC | 0.03% | 0.00% | 34,500 | -14,000 | -28.87% | 68,000,000 | Mar 31, 2023 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -8,518 | -100.00% | - | Mar 31, 2023 |
| UBS GROUP AG | - | - | - | -4,024 | -100.00% | - | Mar 31, 2023 |
| VIDENT INVESTMENT ADVISORY, LLC | 0.03% | 0.00% | 27,778 | -838 | -2.93% | 54,445,000 | Mar 31, 2023 |
| CORNERCAP INVESTMENT COUNSEL INC | 0.15% | 0.06% | 165,400 | -318 | -0.19% | 324,184,000 | Mar 31, 2023 |
| VIDA VENTURES ADVISORS, LLC | 2.11% | 6.12% | 2,282,084 | - | - | 4,472,885,000 | Mar 31, 2023 |
| PERCEPTIVE ADVISORS LLC | 53.33% | 3.33% | 57,558,451 | - | - | 112,814,563,000 | Mar 31, 2023 |
| SCHF (GPE), LLC | 0.87% | 3.24% | 937,500 | - | - | 1,838,000 | Mar 31, 2023 |
As of Mar 31 2023, LianBio's biggest institutional seller is VR ADVISER, LLC. The company sold -4.79M shares of LIAN, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CORMORANT ASSET MANAGEMENT, LP | 3.94% | 0.55% | 4,250,000 | 4,250,000 | 100.00% | 8,330,000 | Mar 31, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.01% | - | 15,494 | 15,494 | 100.00% | 30,213,000 | Mar 31, 2023 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.01% | - | 12,536 | 12,536 | 100.00% | 24,445,000 | Mar 31, 2023 |
LianBio's largest new institutional shareholder by number of shares is CORMORANT ASSET MANAGEMENT, LP, purchased 4.25M shares, valued at $8.33M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VR ADVISER, LLC | - | - | - | -4,793,047 | -100.00% | - | Mar 31, 2023 |
| INNOVIS ASSET MANAGEMENT LLC | - | - | - | -176,192 | -100.00% | - | Mar 31, 2023 |
| THRIVENT FINANCIAL FOR LUTHERANS | - | - | - | -81,168 | -100.00% | - | Mar 31, 2023 |
| VICTORY CAPITAL MANAGEMENT INC | - | - | - | -64,506 | -100.00% | - | Mar 31, 2023 |
| GSA CAPITAL PARTNERS LLP | - | - | - | -19,482 | -100.00% | - | Mar 31, 2023 |
| VIRTU FINANCIAL LLC | - | - | - | -17,456 | -100.00% | - | Mar 31, 2023 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -8,518 | -100.00% | - | Mar 31, 2023 |
| UBS GROUP AG | - | - | - | -4,024 | -100.00% | - | Mar 31, 2023 |
LianBio's largest sold out institutional shareholder by shares sold is VR ADVISER, LLC, sold -4.79M shares, valued at -, as of undefined.
LianBio Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| T. Rowe Price Health Sciences Fund, Inc. | 0.61% | 2,033,954 | - | - | Mar 31, 2024 |
| CORNERCAP GROUP OF FUNDS /VA/ | 0.58% | 42,042 | 15,856 | 60.55% | Sep 30, 2022 |
| BlackRock Health Sciences Trust II | 0.23% | 615,188 | - | - | Mar 31, 2024 |
| T. Rowe Price Equity Series, Inc. | 0.06% | 102,126 | - | - | Mar 31, 2024 |
| AB CAP FUND, INC. | 0.03% | 1,020,505 | - | - | Jan 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.02% | 49,917 | 806 | 1.64% | Feb 29, 2024 |
| ALPS ETF Trust | 0.01% | 67,688 | - | - | Feb 29, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.01% | 590,435 | 33,241 | 5.97% | Feb 29, 2024 |
| Managed Portfolio Series | 0.00% | 55,388 | - | - | Jan 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 97,493 | -38,166 | -28.13% | Feb 29, 2024 |
| AB VARIABLE PRODUCTS SERIES FUND, INC. | 0.00% | 6,544 | - | - | Mar 31, 2024 |
| ETF Series Solutions | 0.00% | 27,778 | - | - | Jan 31, 2024 |
| Fidelity Rutland Square Trust II | 0.00% | 1,313,542 | 662,136 | 101.65% | Feb 29, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 160,058 | - | - | Jan 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 126,427 | - | - | Feb 29, 2024 |
| OHIO NATIONAL FUND INC | 0.00% | 9,273 | - | - | Mar 31, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 38,039 | 38,039 | - | Jan 31, 2024 |
| VICTORY PORTFOLIOS | 0.00% | 13,402 | - | - | Mar 31, 2024 |
| Goldman Sachs ETF Trust | 0.00% | 25,404 | 6,487 | 34.29% | Feb 29, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 25,534 | - | - | Jan 31, 2024 |
| Fidelity Rutland Square Trust II | 0.00% | 111,035 | - | - | Feb 29, 2024 |
| BERNSTEIN SANFORD C FUND INC | 0.00% | 12,649 | - | - | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 581,057 | - | - | Mar 31, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 190,319 | - | - | Feb 29, 2024 |
| EQ ADVISORS TRUST | 0.00% | 27,401 | - | - | Mar 31, 2024 |
| RBB FUND, INC. | 0.00% | 1,693 | - | - | Feb 29, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 38,982 | - | - | Mar 31, 2024 |
| Northern Lights Fund Trust IV | 0.00% | 2,023 | 2,023 | - | Feb 29, 2024 |
| John Hancock Funds II | 0.00% | 47,800 | - | - | Feb 29, 2024 |
| Mercer Funds | 0.00% | 22,765 | 22,765 | - | Mar 31, 2024 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 26,122 | -6,729 | -20.48% | Feb 29, 2024 |
LianBio's largest mutual fund holder by % of total assets is "T. Rowe Price Health Sciences Fund, Inc.", owning 2.03M shares, compromising 0.61% of its total assets.
LianBio Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 31 Mar, 23 | 35 | -10.26% |
| 31 Dec, 22 | 39 | -9.30% |
| 30 Sep, 22 | 43 | -2.27% |
| 30 Jun, 22 | 44 | 22.22% |
| 31 Mar, 22 | 36 | - |
| 31 Dec, 21 | 36 | - |
As of 31 Mar 23, 35 institutions are holding LianBio's shares, representing a decrease of -10.26% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 31 Mar, 23 | 80,205,299 | -1.31% |
| 31 Dec, 22 | 81,273,730 | -3.29% |
| 30 Sep, 22 | 84,038,211 | -2.97% |
| 30 Jun, 22 | 86,612,554 | 0.77% |
| 31 Mar, 22 | 85,948,354 | -3.89% |
| 31 Dec, 21 | 89,425,687 | - |
LianBio (LIAN) has 80.21M shares outstanding as of 31 Mar 23, down -1.31% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 31 Mar, 23 | 74.32% | -0.92% |
| 31 Dec, 22 | 75.01% | -3.67% |
| 30 Sep, 22 | 77.87% | -3.55% |
| 30 Jun, 22 | 80.74% | -19.26% |
| 31 Mar, 22 | 100.00% | - |
| 31 Dec, 21 | 100.00% | - |
As of 31 Mar 23, LianBio is held by 74.32% institutional shareholders, representing a -0.92% negative growth compared to 31 Dec 22.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 31 Mar, 23 | 6 | -25.00% |
| 31 Dec, 22 | 8 | -55.56% |
| 30 Sep, 22 | 18 | 80.00% |
| 30 Jun, 22 | 10 | 150.00% |
| 31 Mar, 22 | 4 | - |
| 31 Dec, 21 | - | - |
6 institutional shareholders have increased their position in LIAN stock as of 31 Mar 23 compared to 8 in the previous quarter (a -25.00% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 31 Mar, 23 | 9 | -10.00% |
| 31 Dec, 22 | 10 | 66.67% |
| 30 Sep, 22 | 6 | -40.00% |
| 30 Jun, 22 | 10 | 150.00% |
| 31 Mar, 22 | 4 | - |
| 31 Dec, 21 | - | - |
9 institutional shareholders have reduced their position in LIAN stock as of 31 Mar 23 compared to 10 in the previous quarter (a -10.00% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Mar, 23 | 35 | -10.26% | 80,205,299 | -1.31% | 74.32% | -0.92% | 6 | -25.00% | 9 | -10.00% |
| 31 Dec, 22 | 39 | -9.30% | 81,273,730 | -3.29% | 75.01% | -3.67% | 8 | -55.56% | 10 | 66.67% |
| 30 Sep, 22 | 43 | -2.27% | 84,038,211 | -2.97% | 77.87% | -3.55% | 18 | 80.00% | 6 | -40.00% |
| 30 Jun, 22 | 44 | 22.22% | 86,612,554 | 0.77% | 80.74% | -19.26% | 10 | 150.00% | 10 | 150.00% |
| 31 Mar, 22 | 36 | - | 85,948,354 | -3.89% | 100.00% | - | 4 | - | 4 | - |
| 31 Dec, 21 | 36 | - | 89,425,687 | - | 100.00% | - | - | - | - | - |
LianBio Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of LianBio's stock was made by Gu Ehong on Apr 11 2024, selling 1,731 shares at $4.34 per share (valued at $7.51K).
LianBio Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | 1 | - |
| Q1 2024 | 5 | 11 | 45.45% |
| Q4 2023 | - | 3 | - |
| Q2 2023 | 6 | - | - |
| Q1 2023 | 8 | 1 | 800.00% |
| Q3 2022 | 2 | - | - |
| Q2 2022 | 14 | - | - |
| Q4 2021 | 17 | 11 | 154.55% |
0 total buy trades, and 1 total sell trades (buy/sell ratio of 0.00%) were made by LianBio's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | - | - |
| Q1 2024 | - | 1 | - |
| Q4 2023 | - | - | - |
| Q2 2023 | - | - | - |
| Q1 2023 | - | 1 | - |
| Q3 2022 | 2 | - | - |
| Q2 2022 | 6 | - | - |
| Q4 2021 | 4 | - | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of LianBio's stocks.
LianBio Peer Ownership
| Ticker | Company |
|---|---|
| NUVB | Nuvation Bio Inc. |
| ACHL | Achilles Therapeutics plc |
| NXTC | NextCure, Inc. |
| LRMR | Larimar Therapeutics, Inc. |
| DAWN | Day One Biopharmaceuticals, Inc. |
| HOOK | HOOKIPA Pharma Inc. |
| SNSE | Sensei Biotherapeutics, Inc. |
| FENC | Fennec Pharmaceuticals Inc. |
| GRPH | LENZ Therapeutics, Inc. |
| TERN | Terns Pharmaceuticals, Inc. |
| INZY | Inozyme Pharma, Inc. |
| ASMB | Assembly Biosciences, Inc. |
| ELDN | Eledon Pharmaceuticals, Inc. |
| ABOS | Acumen Pharmaceuticals, Inc. |
| NLTX | Neurogene Inc. |
| VRCA | Verrica Pharmaceuticals Inc. |
| FIXX | Q32 Bio Inc. |
| MACK | Merrimack Pharmaceuticals, Inc. |
| TIL | Instil Bio, Inc. |
LIAN Ownership FAQ
Who Owns LianBio?
LianBio is owned by institutional shareholders (74.32%), insiders (5.91%), and public (19.78%). The largest institutional shareholder of LianBio is PERCEPTIVE ADVISORS LLC (53.33% of total shares) and the top mutual fund owner is T. Rowe Price Health Sciences Fund, Inc. (0.61% of total shares).
Who are the major institutional shareholders of LianBio?
LianBio's major institutional shareholders are PERCEPTIVE ADVISORS LLC, CORMORANT ASSET MANAGEMENT, LP, VIKING GLOBAL INVESTORS LP, TYBOURNE CAPITAL MANAGEMENT (HK) LTD, and PRICE T ROWE ASSOCIATES INC /MD/. The top five shareholders own together 65.99% of the company's share outstanding.
How many LianBio shareholders are there?
As of Mar 2023, there are 35 institutional shareholders of LianBio.
What percentage of LianBio is owned by PERCEPTIVE ADVISORS LLC?
PERCEPTIVE ADVISORS LLC owns 57.56M shares of LianBio, representing 53.33% of the company's total shares outstanding, valued at $112.81B (as of Mar 2023).
What percentage of LianBio is owned by CORMORANT ASSET MANAGEMENT, LP?
As of Mar 2023, CORMORANT ASSET MANAGEMENT, LP holds 4.25M shares of LianBio (LIAN), compromising 3.94% of the company, valued at $8.33M.
What percentage of LianBio is owned by VIKING GLOBAL INVESTORS LP?
VIKING GLOBAL INVESTORS LP is the third largest holder of LianBio. The company owns 3.56M of the company's shares outstanding (worth $6.95B).